These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11783424)

  • 1. Genotyping and drug response: use of single nucleotide polymorphisms (SNPs) versus haplotypes to predict albuterol efficacy.
    Schubbert S
    AAPS PharmSci; 2001; 3(3):1. PubMed ID: 11783424
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta(2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics*.
    Kukreti R; Bhatnagar P; B-Rao C; Gupta S; Madan B; Das C; Guleria R; Athavale AU; Brahmachari SK; Ghosh B
    Pharmacogenomics; 2005 Jun; 6(4):399-410. PubMed ID: 16004558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of salmeterol on aspirin-induced asthma and on smell].
    Mihălţan F; Muir P; Muir JF
    Rom J Intern Med; 1994; 32(3):235-8. PubMed ID: 7866341
    [No Abstract]   [Full Text] [Related]  

  • 4. Albuterol enantiomers: pre-clinical and clinical value?
    Ameredes BT; Calhoun WJ
    Front Biosci (Elite Ed); 2010 Jun; 2(3):1081-92. PubMed ID: 20515778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol.
    Choudhry S; Que LG; Yang Z; Liu L; Eng C; Kim SO; Kumar G; Thyne S; Chapela R; Rodriguez-Santana JR; Rodriguez-Cintron W; Avila PC; Stamler JS; Burchard EG
    Pharmacogenet Genomics; 2010 Jun; 20(6):351-8. PubMed ID: 20335826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma.
    Taylor DR; Epton MJ; Kennedy MA; Smith AD; Iles S; Miller AL; Littlejohn MD; Cowan JO; Hewitt T; Swanney MP; Brassett KP; Herbison GP
    Am J Respir Crit Care Med; 2005 Sep; 172(6):700-3. PubMed ID: 15976384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):583-91; quiz 591-2, 659. PubMed ID: 12839314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.
    Johnson M; Rennard S
    Chest; 2001 Jul; 120(1):258-70. PubMed ID: 11451847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salmeterol for the prevention of high-altitude pulmonary edema.
    Bärtsch P; Mairbäurl H
    N Engl J Med; 2002 Oct; 347(16):1282-5; author reply 1282-5. PubMed ID: 12397659
    [No Abstract]   [Full Text] [Related]  

  • 10. Salmeterol: a novel, long-acting beta 2-agonist.
    Meyer JM; Wenzel CL; Kradjan WA
    Ann Pharmacother; 1993 Dec; 27(12):1478-87. PubMed ID: 7905757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting beta 2-agonists. Role in primary care asthma treatment.
    D'Urzo AD
    Can Fam Physician; 1997 Oct; 43():1773-7. PubMed ID: 9356758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic aspects of salmeterol therapy.
    Buchwald A; Hochhaus G
    Int J Clin Pharmacol Ther; 1998 Dec; 36(12):652-60. PubMed ID: 9877002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmeterol.
    Ind PW
    Br J Hosp Med; 1990 Nov; 44(5):343-4. PubMed ID: 1980426
    [No Abstract]   [Full Text] [Related]  

  • 14. Salmeterol.
    Med Lett Drugs Ther; 1994 Apr; 36(921):37-9. PubMed ID: 7909139
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.
    Rennard SI; Anderson W; ZuWallack R; Broughton J; Bailey W; Friedman M; Wisniewski M; Rickard K
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1087-92. PubMed ID: 11316640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bronchodilator effect of salmeterol and inhibition of bronchial hyperreactivity].
    Boulet LP
    Rev Mal Respir; 1992; 9 Suppl 1():R11-3. PubMed ID: 1350363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmeterol: a long acting bronchodilator.
    Bhadoria DP; Bhadoria P
    J Postgrad Med; 1995; 41(1):24-6. PubMed ID: 10740700
    [No Abstract]   [Full Text] [Related]  

  • 18. Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: response by beta-agonist reversibility.
    Bleecker ER; Emmett A; Crater G; Knobil K; Kalberg C
    Pulm Pharmacol Ther; 2008 Aug; 21(4):682-8. PubMed ID: 18541448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from structure-function studies in asthma: myths and truths about what we teach.
    Irvin CG
    J Appl Physiol (1985); 2006 Jul; 101(1):7-9. PubMed ID: 16782831
    [No Abstract]   [Full Text] [Related]  

  • 20. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma.
    Craven D; Kercsmar CM; Myers TR; O'riordan MA; Golonka G; Moore S
    J Pediatr; 2001 Jan; 138(1):51-58. PubMed ID: 11148512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.